Correlation Between Immix Biopharma and Cns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Cns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Cns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and Cns Pharmaceuticals, you can compare the effects of market volatilities on Immix Biopharma and Cns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Cns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Cns Pharmaceuticals.
Diversification Opportunities for Immix Biopharma and Cns Pharmaceuticals
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Immix and Cns is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Cns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cns Pharmaceuticals and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Cns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cns Pharmaceuticals has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Cns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Immix Biopharma and Cns Pharmaceuticals
Given the investment horizon of 90 days Immix Biopharma is expected to generate 0.5 times more return on investment than Cns Pharmaceuticals. However, Immix Biopharma is 2.0 times less risky than Cns Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Cns Pharmaceuticals is currently generating about -0.23 per unit of risk. If you would invest 231.00 in Immix Biopharma on August 24, 2024 and sell it today you would lose (63.00) from holding Immix Biopharma or give up 27.27% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immix Biopharma vs. Cns Pharmaceuticals
Performance |
| Timeline |
| Immix Biopharma |
| Cns Pharmaceuticals |
Immix Biopharma and Cns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immix Biopharma and Cns Pharmaceuticals
The main advantage of trading using opposite Immix Biopharma and Cns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Cns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will offset losses from the drop in Cns Pharmaceuticals' long position.| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
| Cns Pharmaceuticals vs. ZyVersa Therapeutics | Cns Pharmaceuticals vs. Immix Biopharma | Cns Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Cns Pharmaceuticals vs. Ocean Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |